ऐप डाउनलोड करें
उत्पाद या दवाइयाँ जिनमें Study examines the relationship between COVID-19 and superspreaders है
- Proctosedyl BD Cream - ₹116
- Anovate Ointment - ₹117
- Covifor Injection - ₹3780
- Fabiflu 400 Tablet - ₹856
- Fabiflu 200 Mg Tablet - ₹1292
- Fabiflu (Favipiravir) 200 Mg Tablet - ₹1292
- Fabiflu (Favipiravir) 400 Mg Tablet - ₹1224
- Pilo GO Cream - ₹75
- Anovate Cream - ₹111
- Remdesivir Injection - ₹10500
- Molusafe Capsule - ₹457
- Movfor 200 Mg Capsule - ₹2490
- Molflu 200 Mg Capsule - ₹1400
- Molulife 200 Capsule - ₹1399
- Cipmolnu 200 Mg Capsule - ₹2000
- Molxvir 200 Mg Capsule - ₹1520
- Alzumab Injection - ₹8229
- Immunocin Alpha Plus 1.6mg Injection - ₹5998
- Imualfa 1.6mg Injection 1ml - ₹2628
- Molnutor 200 Mg Capsule - ₹2000
संदर्भ
- Sneppen K and Simonsen L. Impact of Superspreaders on dissemination and mitigation of COVID-19 medRxiv. 2020 May. [Internet]
- Stein RA. Super-spreaders in infectious diseases International Journal of Infectious Diseases. 2011 Aug; 15(8): 510-513.
- Hamner L et al. High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice — Skagit County, Washington, March 2020 Morbidity and Mortality Weekly Report, CDC. 2020 May; 69(19);606–610.
- Frieden TR and Lee CT. Identifying and Interrupting Superspreading Events—Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2 Emerging Infectious Diseases. 2020 Jun; 26(6):1059-1066.
- Woolhouse ME et al. Heterogeneities in the Transmission of Infectious Agents: Implications for the Design of Control Programs Proc Natl Acad Sci USA. 1997 Jan; 94(1):338-42.
